Cömert Önder, F. Et Al. 2020. Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo. BioRxiv , vol.2020, no.11 , 1-36.

Cömert Önder, F., Kahraman, N., Bellur Atici, E., Çağır, A., Kandemir, H., Tatar, G., ... Taşkın Tok, T.(2020). Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo. BioRxiv , vol.2020, no.11, 1-36.

Cömert Önder, FERAH Et Al. "Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo," BioRxiv , vol.2020, no.11, 1-36, 2020

Cömert Önder, FERAH C. Et Al. "Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo." BioRxiv , vol.2020, no.11, pp.1-36, 2020

Cömert Önder, F. Et Al. (2020) . "Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo." BioRxiv , vol.2020, no.11, pp.1-36.

@article{article, author={FERAH CÖMERT ÖNDER Et Al. }, title={Target-driven design of a coumarinyl chalcone scaffold based novel EF2 Kinase inhibitor suppresses breast cancer growth in vivo}, journal={BioRxiv}, year=2020, pages={1-36} }